Square Pharm recommends 120pc cash dividend
Square Pharmaceutical board of directors has recommended 120 per cent cash dividend for the year ended June 30, 2025.
Square Pharmaceutical board of directors has recommended 120 per cent cash dividend for the year ended June 30, 2025.